Equity Overview
Price & Market Data
Price: $1.09
Daily Change: -$0.09 / 8.26%
Daily Range: $1.02 - $1.18
Market Cap: $4,858,606
Daily Volume: 224,416
Performance Metrics
1 Week: -1.82%
1 Month: -17.56%
3 Months: -26.53%
6 Months: -85.55%
1 Year: -95.56%
YTD: -8.47%
Company Details
Employees: 57
Sector: Health technology
Industry: Medical specialties
Country:
Details
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.